8/31/2023IQVIA: Chinese Retail Pharmacy Sales up 8.9% in MAT Q2/2023

8/31/2023NMPA and Chinese Customs Announce Addition of Taizhou as a Drug Import...

8/31/2023NHSA to Cancel Hospital Payment Rights for Drug and Consumable Procure...

8/31/2023MC2 Thera and Huadong Pharma Enter LIcense Deal for Plague Psoriasis D...

8/31/2023Recent Official and Executive Moves

8/31/2023Drug R&D and Product Registration News Digest August 2023 (5)

8/31/2023Financial-related Company News Digest (August 2023)

8/31/2023Discussion of Support Issue of Biological Sequence Claims from an Inva...

8/31/2023China Squeezes Healthcare Swamp with Crackdown and Cost Containment am...

8/30/2023How to Reduce the Risk of Pharmaceutical Patent Application in China?

8/30/2023Upcoming Event: 2023 Pharma CI USA Conference & Exhibition

8/30/2023Upcoming Event: 15th Annual Pharma Market Research Conference

8/30/2023Review of Rising Sales Expenditures Trend of A and H Share-Listed Chin...

8/30/2023CDE Publicizes the List of Reference Formulations for GQCE Studies (73...

8/29/2023NMPA Announces Package Insert Revision of Two Drug Products

8/29/2023NMPA Announces OTC Switch of Paracetamol Orally Dispersion Tablet

8/29/2023Former Star Official of China's Healthcare Reform and VBP Architect ...

8/29/2023NMPA Set to Raise the Bar for Conditional Approval Process of New Drug...

8/29/2023CanSino to Acquire 10% Stake in Malaysian Vaccine Maker Solution

8/29/2023Mounjaro's China Approval Imminent as Domestic Competitors Enter Clini...

8/28/2023Regulation of Drug and Medical Device Advertising in China: An Industr...

8/28/2023Verastem Oncology Enters Partnerships with GenFleet Therapeutics to Ad...

8/28/2023CDE Solicits Second Round Comments on Two Pharmaceutical Change Resear...

8/28/2023Chinese Pharma CEOs Emphasize Strategic R&D Selection in Tough Fundrai...

8/25/2023CDE Seeks Comments on Draft ICH Guidelines M7(R2)

8/25/2023NMPA Issues Announcement for Applicability of ICH Guidelines Q12

8/25/2023NMPA Solicits Comments on the Working Procedures for Evaluation and Ap...

8/25/2023Domestic Pharma Sealed Ten Outlicensing Deals in H1/2023 (Updated)

8/25/2023IQVIA: Overall Chinese Pharma Market Growth Up 0.3% in 2022

8/25/2023State Council Adopts New Action Plan for High-quality Development of P...

Page:91/775 Total number of articles:23233: [First][<<] [89] [90] [91] [92] [93] [>>] [End]